ADMA DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – ADMA

Rosen Law Firm reminds investors who purchased ADMA Biologics securities between August 9, 2024 and March 25, 2026 of the August 10, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges ADMA engaged in undisclosed related party transactions, channel stuffing, and lacked adequate internal controls, resulting in materially false statements about the company's business and operations.